Advertisement

Special Populations and Topics in Adolescent Substance Use

  • Brittany L. Carney
  • Sarah M. BagleyEmail author
Chapter

Abstract

Youth who use substances face increased risks and require additional treatment considerations. This chapter examines special issues affecting youth who use substances including injection drug use, pregnancy, homelessness, incarceration, and sexual identity. Youth who inject drugs require a multidisciplinary and patient-centered approach which may include pharmacologic or behavioral health treatment, harm reduction, and overdose education/prevention. Pregnant adolescents who use substances face acute and chronic effects for mother and baby that need to be addressed during pregnancy and the postpartum period. Lesbian, gay, bisexual, transgender, queer, and questioning (LGBTQ) youth face high rates of substance use and may have difficulty accessing adequate care. Incarcerated and homeless youth also face unique barriers to accessing care. General considerations that can be tailored to each individual’s needs will be highlighted by examining the prevalence of use, adverse consequences, and clinical recommendations for providers through these special populations.

Keywords

Opioids Pregnancy Injection drug use Overdose Homeless LGBTQ 

References

  1. 1.
    Committee on Substance Abuse, Levy SJL, Kokotailo PK. Substance use screening, brief intervention, and referral to treatment for pediatṣricians. Pediatrics. 2011;128(5):e1330–40.CrossRefGoogle Scholar
  2. 2.
    Collier MG, Doshani M, Asher A. Using population based hospitalization data to monitor increases in conditions causing morbidity among persons who inject drugs. J Community Health. 2018;43(3):598–603.CrossRefGoogle Scholar
  3. 3.
    Centers for Disease Control and Prevention. Youth risk behavior survey data; 2015. www.cdc.gov/yrbs. Accessed 3 Feb 2018.
  4. 4.
  5. 5.
    Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):pii:e20161893.CrossRefGoogle Scholar
  6. 6.
    Godley SH, Meyers RJ, Smith JE, Karvinen T, Titus JC, Godley MD, et al. Adolescent community reinforcement approach (ACRA) for adolescent cannabis users. Rockville: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration; 2001.Google Scholar
  7. 7.
    Kirby KC, Versek B, Kerwin ME, et al. Developing community reinforcement and family training (CRAFT) for parents of treatment-resistant adolescents. J Child Adolesc Subst Abuse. 2015;24(3):155–65.CrossRefGoogle Scholar
  8. 8.
    US Department of Health and Human Services. Item of interest: FDA approves PrEP therapy for adolescents at risk of HIV. https://www.nichd.nih.gov/newsroom/releases/051618-PrEP. Accessed 16 May 2018.
  9. 9.
    Centers for Disease Control and Prevention, Department of Health and Human Services. US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States-2014:67. https://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf. Accessed 3 Feb 2018.
  10. 10.
    Hedegaard H, Warner M, Minino AM. Drug overdose deaths in the United States, 1999–2016. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017:8. https://www.cdc.gov/nchs/data/databriefs/db294.pdf. Accessed 3 Feb 2018.
  11. 11.
    Curtin SC, Tejada-Vera B, Warner M. Drug overdose deaths among adolescents aged 15–19 in the United States: 1999–2015. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017:8. https://www.cdc.gov/nchs/data/databriefs/db282.pdf. Accessed 3 Feb 2018.
  12. 12.
    Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.CrossRefGoogle Scholar
  13. 13.
    Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med. 2016;374(9):843–52.CrossRefGoogle Scholar
  14. 14.
    Heil SH, Jones HE, Arria A, et al. Unintended pregnancy in opioid-abusing women. J Subst Abus Treat. 2011;40(2):199–202.CrossRefGoogle Scholar
  15. 15.
    Levy S, Weiss R, Sherritt L, et al. An electronic screen for triaging adolescent substance use by risk levels. JAMA Pediatr. 2014;168(9):822.CrossRefGoogle Scholar
  16. 16.
    Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002;156(6):607.CrossRefGoogle Scholar
  17. 17.
    Wright TE, Terplan M, Ondersma SJ, et al. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstet Gynecol. 2016;215(5):539–47.CrossRefGoogle Scholar
  18. 18.
    Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abus Treat. 2007;32(2):189–98.CrossRefGoogle Scholar
  19. 19.
    Tan CH, Denny CH, Cheal NE, Sniezek JE, Kanny D. Alcohol use and binge drinking among women of childbearing age – United States, 2011–2013. MMWR Morb Mortal Wkly Rep. 2015;64(37):1042–6.CrossRefGoogle Scholar
  20. 20.
    Young-Wolff KC, Tucker L-Y, Alexeeff S, et al. Trends in self-reported and biochemically tested marijuana use among pregnant females in California from 2009–2016. JAMA. 2017;318(24):2490.CrossRefGoogle Scholar
  21. 21.
    Brown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS. Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002–2014. JAMA. 2017;317(2):207–9.CrossRefGoogle Scholar
  22. 22.
    Crume TL, Juhl AL, Brooks-Russell A, Hall KE, Wymore E, Borgelt LM. Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: the association between maternal characteristics, breastfeeding patterns, and neonatal outcomes. J Pediatr. 2018;197:90–6.CrossRefGoogle Scholar
  23. 23.
    Hennessy G. Marijuana and pregnancy. Am J Addict. 2018;27(1):44–5.CrossRefGoogle Scholar
  24. 24.
    Curtin SC, Matthews TJ. Smoking prevalence and cessation before and during pregnancy: data from the birth certificate, 2014. Natl Vital Stat Rep Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst. 2016;65(1):1–14.Google Scholar
  25. 25.
    Drake P, Driscoll AK, Matthews TJ. Cigarette smoking during pregnancy: United States, 2016. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2018:8. https://www.cdc.gov/nchs/data/databriefs/db305.pdf. Accessed 7 Mar 2018.
  26. 26.
    Salihu HM, Mogos MF, Salinas-Miranda AA, Salemi JL, Whiteman VE. National trends in maternal use of opioid drugs among pregnancy-related hospitalizations in the United States, 1998 to 2009. Am J Perinatol. 2015;32(3):289–98.PubMedGoogle Scholar
  27. 27.
    Huebner DM, Thoma BC, Neilands TB. School victimization and substance use among lesbian, gay, bisexual, and transgender adolescents. Prev Sci Off J Soc Prev Res. 2015;16(5):734–43.CrossRefGoogle Scholar
  28. 28.
    Marshal MP, Friedman MS, Stall R, et al. Sexual orientation and adolescent substance use: a meta-analysis and methodological review. Addict Abingdon Engl. 2008;103(4):546–56.CrossRefGoogle Scholar
  29. 29.
    Hockenberry S, Wachter A, Sladky A. Juvenile residential facility census selected findings. US Department of Justice, Office of Justice Programs, Office of Juvenile Justice and Delinquency Prevention; 2016:20. https://www.ojjdp.gov/pubs/250123.pdf. Accessed 3 Feb 2018.
  30. 30.
    De Rosa CJ, Montgomery SB, Kipke MD, Iverson E, Ma JL, Unger JB. Service utilization among homeless and runaway youth in Los Angeles, California: rates and reasons. J Adolesc Health Off Publ Soc Adolesc Med. 1999;24(3):190–200.CrossRefGoogle Scholar
  31. 31.
    Krüsi A, Fast D, Small W, Wood E, Kerr T. Social and structural barriers to housing among street-involved youth who use illicit drugs. Health Soc Care Community. 2010;18(3):282–8.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Tozer K, Tzemis D, Amlani A, et al. Reorienting risk to resilience: street-involved youth perspectives on preventing the transition to injection drug use. BMC Public Health. 2015;15:800.CrossRefGoogle Scholar
  33. 33.
    Cheng T, Kerr T, Small W, Nguyen P, Wood E, DeBeck K. High prevalence of risky income generation among street-involved youth in a Canadian setting. Int J Drug Policy. 2016;28:91–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Graduate School of NursingUniversity of Massachusetts Medical School, University of Massachusetts WorcesterWorcesterUSA
  2. 2.Section of General Internal Medicine, Department of MedicineBoston University School of Medicine/Boston Medical CenterBostonUSA
  3. 3.Division of General Pediatrics, Department of PediatricsBoston University School of Medicine/Boston Medical CenterBostonUSA

Personalised recommendations